United States · FDA National Drug Code directory
EVRYSDI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-175_a0597961-b4b9-47ec-961a-919fa9ffba95
- Product NDC
- 50242-175
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Risdiplam
- Labeler
- Genentech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200807
- Source listing expiry
- 20271231
Source-listed ingredients
- RISDIPLAM — .75 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (50242-175-07) / 80 mL in 1 BOTTLE, GLASS · 50242-175-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →